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SUMMARY 
 
Monosodium glutamate (MSG), an established excitotoxic food additive, has been found to induce 
oxidative stress in all tissues. To examine the protective effects of ivermectin on MSG-induced excitotoxicity, 28 
male albino rats were randomized into four groups. Group 1, the control, received 1 ml of oral distilled water, 
group 2 was administered an aqueous solution of MSG (4 mg/kg body weight/day). Group 3 was co-administered 
with the same dose of MSG and 0.4 mg/kg body weight of ivermectin, while group 4 rats received orally the same 
dose of MSG for 2 weeks, after which ivermectin was administered orally for 1 week. Administration of MSG 
orally for 21 days and for 14 days, followed by oral administration of ivermectin for 7 days, significantly increased 
(p < 0.05) glutathione-S-transferase, nitric oxide synthase, superoxide dismutase and catalase activities as well as 
malondialdehyde and intracellular Ca2+ concentrations while Na+ - K+ - ATPase, Ca2+ - Mg2+ - ATPase, acid phos-
phatase (ACP) and alkaline phosphatase (ALP) activities were significantly reduced (p < 0.05) compared to the 
control. However, co-administration of MSG and ivermectin for 21 days did not show any significant difference (p 
> 0.05) in all the parameters studied compared to the control. This result suggests that ivermectin may protect 
against MSG-induced excitotoxicity in rats. 
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INTRODUCTION 
 
It is known that under normal physiological con-
ditions, an effective Ca2+ buffered system occurs after the 
neurotransmitter-mediated opening of glutamate, N-me-
thyl-D-aspartate (NMDA), alpha-amino-3-hydroxy-5-me- 
thyl-4-isoxazolepropionic (AMPA) receptor channels, 
and voltage-dependent Ca2+ channels that maintain the 
intracellular Ca2+ concentration in response to glutamate 
release (1, 2). Many chemicals have demonstrated that 
they possess the ability to disrupt this buffer system, re-
sulting in increased postsynaptic calcium levels, produ-
cing toxic effects on neurons and other excitable tissues 
(3). 
Excitotoxicity is a pathological process that can 
lead to the damage and destruction of nerve cells due to 
hyperstimulation of neurotransmitters such as glutama-
te and other similar substances. This process takes place 
when the excitatory neurotransmitter receptors, gluta-
mates (glutamate receptors), such as the NMDA recep-
tor and the AMPA receptor, become over-activated. One 
of these chemicals is monosodium glutamate (MSG). 
MSG is an additive in food that is widely used as a fla-
vor enhancer. It is found in significant amounts in pro-
cessed foods and has a chemical composition similar to 
that of neurotransmitters of brain glutamate. This amino 
acid can act on several types of receptors. The receptors 
are divided into two major groups: ionotropic glutamate 
receptors (iGluR) and metatropic glutamate receptors 
(mGluR) (4). MSG is an established neuro- and excito- 
toxin (5, 6). 
During the first week of newborn rats, the admi-
nistration of MSG to newborn rats induces a neurodege-
nerative process, characterized by many neurochemical 
alterations of surviving neurons in the brain (7). Altho-
ugh the mechanism of action of MSG as an excitotoxin 
still remains unclear, however, Bojanić et al. (8) hypo-
thesized that neural membrane permeability for calcium 
could be altered by high concentration of MSG.  
Many glutamate receptor antagonist compounds 
such as diltiazem and some macrolide antibiotics have 
demonstrated a protective effect against MSG toxicity 
when co-administered to rats (8). Ivermectin (22, 23-
dihydroavermectin B1a), a member of the macrocyclic 
lactones (macrolides) avermectin class isolated from 
Streptomyces avermitilis, is a potent antihelminthic agent 
used to treat onchocerciasis (river blindness) (9) and 
lymphatic filariasis (elephantiasis) (10) in humans. It ap-
pears as either white or yellowish-white powder with a 
melting point of 156 °C. It is easily soluble in methanol 
and each tablet contains cellulose, pre-crystallized starch, 
magnesium, butylated hydroxyanisole, and citrate pow-
der. 
As a macrocyclic lactone, ivermectin produces a 
flaccid paralysis of somatic worm musculature and inhi-
bits parasite feeding by blocking pharyngeal pumping 
(11), suggesting that a disturbance of ingestion is the 
main action of this compound. The half-maximal effect-
tive concentration (EC50) for the biological activity of 
ivermectin is strongly correlated with their ability to ac-
tivate glutamate-sensitive channels and their binding 
affinity for membrane preparations of nematodes (12). 
Ivermectin induces the release of Ca2+ from reticulum of 
the sarcoplasm (13). This may be due in part to the ac-
tivation of glutamate-sensitive channels via ryanodine 
(RyR) Ca2+ receptor channels in excitable tissues. An inte-
resting observation is the ability of macrolide antibiotics 
to exert a protective effect against glutamate excitotoxi-
city (14). This protective potential may depend on the 
structure, with larger nucleus macrolides being more 
effective (15). 
However, there is a dearth of information regard-
ing the potential of compounds that are not antibacterial 
but possess the macrocyclic core structure to exhibit such 
a protective property. To this end, we assessed the pro-
tection potential of ivermectin against excitotoxicity in-
duced by monosodium glutamate in rats. 
 
MATERIAL AND METHODS 
 
Chemicals 
 
The AMP-buffered sodium thymolphthalein mo-
nophosphate substrate used for ALP was a product of 
Teco Diagnostics, Lakeview Avenue, Anaheim, Canada. 
Ivermectin and monosodium glutamate were the pro-
ducts of Merck and Co. England and Ajinomoto, Chi-
cago, respectively. All other reagents used were of ana-
lytical grade, purchased from Merck and Co. England 
and were prepared in all-glass distilled water. The rea-
gents were stored in clean and sealed reagent bottles. 
 
Experimental animals 
 
An aggregate of 28 female Rattus novergicus (albi-
no rats) of average weight 169.32 g ± 5.22 g were obta-
ined from the Animal Conservation Unit of the Depar-
tment of Biochemistry, University of Ilorin, Ilorin, Kwara 
State, Nigeria. The animals were kept in plastic cages 
under standard laboratory conditions and had free ac-
cess to rat granules and tap water ad libitum. The studies 
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are in accordance with the Principles of Animal Care 
(16). 
 
Experimental design 
 
The rats were randomly grouped into four gro-
ups and each group comprised seven rats. Group 1 ser-
ved as a control and received 1 ml of oral distilled water. 
Group 2 received orally an aqueous solution of MSG (4 
mg / kg body weight / day). Group 3 received concomi-
tant administration of 4 mg / kg body weight of MSG 
and 0.4 mg / kg body weight of ivermectin (IVER), while 
group 4 rats received 4 mg / kg body weight of MSG 
orally for 2 weeks after which ivermectin (0.4 mg/kg 
body weight) was orally administered for 1 week. The 
treatments lasted 21 days and the rats were sacrificed by 
decapitation 24 hours after the last administration. The 
brain was collected and perfused in normal saline, after 
which tissue homogenate was prepared. 
 
Biochemical analysis 
 
The activity of acid phosphatase (ACP) was ana-
lyzed by adopting the method of Armstrong (17). The 
method of Bassey et al. (18) with slight modification as 
described by Wright and Plummer (19) was used to 
assay for alkaline phosphatase (ALP) activity. ATPase 
activities were determined using the method of Ronner 
et al. (20) as modified by Bewaji et al. (21) and catalase 
(CAT) by the method of Sinha (22). The method des-
cribed by Varshney and Kale (23) was employed to de-
termine the concentration of malondialdehyde (MDA). 
The activities of glutathione-S-transferase (GST), nitric 
oxide synthase (NiOS) and superoxide dismutase (SOD) 
were analyzed by adopting the procedure of Habig et al. 
(24), Bredt et al. (25) and Oyanagui (26), respectively. 
Reduced glutathione (GSH) and calcium ion concentra-
tion were obtained by the method of Moron et al. (27) 
and Chu et al. (28), respectively. 
 
Statistical analysis 
 
Comparisons among groups were carried out us-
ing a Duncan’s multiple range test (29) and values were 
considered to be significant at p < 0 .05. 
 
RESULTS 
 
Co-administration of MSG and ivermectin for 21 
days in rats revealed no significant difference (p > 0.05) 
in brain GSH and MDA concentrations and in GST acti-
vity compared to control. However, the administration 
of MSG alone for 21 days and 14 days, followed by the 
administration of ivermectin for 7 days, resulted in a sig-
nificant (p < 0.05) decrease in the level of these parame-
ters compared with the control (Table 1).  
There was a significant (p < 0.05) increase in cal-
cium ion concentration in the brains of MSG-treated rats 
alone and those administered MSG and ivermectin com-
pared to the control group, but the co-administered gro-
ups with MSG and ivermectin did not show any sig-
nificant difference (p > 0.05) compared to the control. In 
addition, the activities of Na+ - K+ and Ca2+ - Mg2+ 
ATPases in the brain tissues of group 2 rats (MSG alone 
for 21 days) and group 4 (MSG for 14 days and ivermec-
tin for 7 days) were significantly increased while co-ad-
ministration of both chemicals showed no significant 
change (p > 0.05) (Table 2).  
 
 
 
Table 1. The effect of administration of monosodium glutamate (MSG) and ivermectin (IVER) on reduced 
glutathione (GSH), glutathione S-transferase (GST) activity and malondialdehyde formation in rat brain 
 
Groups 
GSH 
µg g-1 protein 
GST 
nmol min-1 mg-1 protein 
MDA 
nmol mg-1 protein 
Control 1.70 + 0.11a 72.51 + 1.86a 0.61 + 0.04a 
MSG 0.55 + 0.03b 111.94 + 7.50b 9.57 + 0.55b 
MSG+IVER 1.91 + 0.12a 74.37 + 4.30a 0.74 + 0.03a 
IVER after MSG 0.49 + 0.02b 114.37 + 9.82b 10.00 + 0.90b 
Values are mean (n = 7) ± SEM. Values with different alphabets in each column are significantly different at *p < 0.05 
 
Unauthentifiziert   | Heruntergeladen  23.09.19 08:32   UTC
O r i g i n a l  a r t i c l e  
Acta facultatis medicae Naissensis 2019; 36(1):38-47                                       41 
Table 2. The effect of administration of monosodium glutamate (MSG) and ivermectin (IVER) 
on Ca2+ level, Na+ - K+ and Ca2+ - Mg2+ ATPase activities in rat brain 
 
Groups 
Ca2+ 
mg 100 ml-1g wet weight-1 
Na+- K+ ATPase 
µmol mg-1 protein hr-1 
Ca2+- Mg2+ ATPase 
µmol mg-1 protein hr-1 
Control 8.12 + 0.71a 0.47 + 0.02a 1.21 + 0.11a 
MSG 19.57 + 1.10b 0.16 + 0.01b 0.97 + 0.07b 
MSG+IVER 7.07 + 0.41a 0.51 + 0.03a 1.19 + 0.10a 
IVER after MSG 17.97 + 1.52b 0.18 + 0.01b 0.99 + 0.07b 
Values are mean ( n = 7) ± SEM. Values with different alphabets in each column are significantly different at *p < 0.05 
 
 
 
The brain activity of superoxide dismutase (SOD), 
nitric oxide synthase (NiOS) and catalase of rats in  
groups 2 and 4 increased significantly (p < 0.05), while 
rats co-administered with MSG and ivermectin (group 
3) showed no significant difference (p > 0.05) when com-
pared to the control as represented in Table 3.  
The effect of administration of monosodium glu-
tamate (MSG) and ivermectin (IVER) on the activities of 
acid phosphatase (ACP) and alkaline phosphatase (ALP) 
in rat brain tissue as presented in Table 4 has a similar 
pattern to the results presented in Table 1. 
 
 
Table 3. The effect of administration of monosodium glutamate (MSG) and ivermectin (IVER) on the 
activities of nitric oxide synthase (NiOS), superoxide dismutase (SOD) and catalase (CAT) in rat brain 
 
Groups 
NiOS 
oUnit mg-1 protein 
SOD 
µmol min-1 mg-1 protein 
CAT 
µmol min-1 mg-1 protein 
Control 94.11 + 7.40a 1001.32 + 61.42a 0.35 + 0.01a 
MSG 122.48 + 10.11b 1189.24 + 65.91b 2.33 + 0.10b 
MSG+IVER 90.41 + 6.50a 998.17 + 21.66a 0.29 + 0.02a 
IVER after MSG 121.12 + 11.14b 1178.15 + 71.70b 2.21 + 0.19b 
Values are mean (n = 7) ± SEM. Values with different alphabets in each column are significantly different at *p < 0.05 
One unit of NiOS is defined as the amount of the enzyme that oxidizes 1 mole of NADPH= per hour at 37 OC. 
 
 
 
Table 4: The effect of administration of monosodium glutamate (MSG) and ivermectin (IVER) on the 
activities of acid phosphatase (ACP) and alkaline phosphatase (ALP) in rat brain 
 
Groups 
ACP 
µmol mg-1 protein min-1 
ALP 
µmol mg-1 protein min-1 
Control 14.45+1.04a 89.30+6.51a 
MSG 6.18+0.51b 22.73+2.11b 
MSG+IVER 15.16+1.31a 91.17+7.21a 
IVER after MSG 7.01+0.43b 23.11+2.01b 
Values are mean (n = 7) ± SEM. Values with different alphabets in each column are significantly different at *p < 0.05 
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DISCUSSION 
 
Sharma (30) demonstrated that administration of 
monosodium glutamate (MSG) at high concentrations 
induces oxidative stress in different organs. Oxidative 
stress is a characteristic feature in a number of neuro-
degenerative disorders such as stroke, Parkinson's di-
sease and Alzheimer's disease (31). The brain is parti-
cularly vulnerable to oxidative stress injury because of 
its high rate of oxidative metabolic activity (32), high 
content of polyunsaturated fatty acids, relatively low 
antioxidant capacity, the abundance of redox-active tran-
sition metal ions (33) and nonreplicating nature of its 
neuronal cells (34). Oxidative stress results from an im-
balance between the concentration of free radicals (re-
active oxygen species) and the antioxidant system (35). 
In order for reactive oxygen species (ROS) to be scaveng-
ed, different defense systems known as antioxidant en-
zymes (such as superoxide dismutase, glutathione per-
oxidase, and catalase) and nonenzymatic (e.g gluta-
thione) are present in the brain (32). Another possible 
action of MSG is through the activation of the glutamate 
receptor channels which induce the flux of Ca2+ into the 
cytosol from the stored vesicles and/or outside the cell. 
Elevated Ca2+ concentration can activate various Ca2+-
dependent degradative enzymes (e.g., phospholipases, 
proteases, endonucleases), which may contribute to cell 
death (36). This mechanism can also occur through oxi-
dative stress. Oxidative stress may cause impairment in 
the transport and subsequent perturbation of intracel-
lular calcium ion homeostasis, resulting in a sustained 
increase in cytosolic calcium ion level.  
In addition to the brain antioxidants, the blood-
brain barrier is an important neuroprotective device re-
gulating the movement of substances into the brain (37). 
p-glycoprotein is an essential constituent of the blood-
brain barrier (BBB). Many macrocyclic lactones interact 
differently with p-glycoprotein and have different p-
glycoprotein efflux potential. The efflux activity of mam-
ma-lian multidrug resistance protein 1 (mdr1) appears to 
be critically important for preventing central nervous 
system toxicity by ivermectin and other avermectins 
(38). Despite the wide range of biological effects, the 
cellular and molecular mechanisms of action for macro-
cyclic lactone ring-containing compounds on neuropro-
tective effects are yet to be known but it is likely that 
they are partly mediated by altered calcium ion trans-
port across the endoplasmic reticulum, similar to those 
reported in the reticulum of the sarcoplasm (39). Ano-
ther possibility is that the interaction of ivecmetrin with 
p-glycoproteins may impair the transport function of the 
BBB (40) thereby preventing the influx of toxins across 
the barrier.  
The significant increase in GST activity and drop 
in GSH concentration of the rats administered MSG 
alone for 21 days and those that later received ivermectin 
orally is an indication that free radicals-induced oxi-
dative stress is in part the mode of action of excitotoxic 
effects of MSG. Reduced glutathione is a substrate for 
conjugation reaction, an important step in the detoxi-
fication process with its thiol (SH) group being a reduc-
ing agent and offer protection from oxidative damage 
caused by reactive oxygen species (41). GSH can dimi-
nish oxidative stress either through protection of the de-
toxifying enzymes by increasing the efficacy of nicotin-
amide adenine dinucleotide phosphate (NADPH), or by 
helping in the elimination of compounds which produce 
peroxidation in the cell membranes (42). This perhaps 
may be among other reasons for the decreased level of 
GSH observed in this study. The decrease in GSH con-
centration recorded from this study is in accordance 
with the report of Neveen and Iman (32). However, the 
effect of co-administration of MSG and ivermectin on the 
rats is possibly due to the interaction of ivermectin with 
the BBB p-glycoproteins thus preventing the increased 
accumulation of MSG in the brain. Glutamate does not 
easily cross the blood-brain barrier; rather, it is trans-
ported as a result of high affinity transport system (43), 
as it has been proposed that ivermectin is a substrate of 
p-glycoprotein (44). Therefore, p-glycoprotein may have 
a greater affinity for ivermectin, which may continue to 
mediate the efflux of ivermectin, there-by negating the 
influx of MSG and consequential accretion in the brain. 
This is supported by the non-significant change in 
all the parameters studied for this group of rats, indi-
cating the absence of oxidative stress or excitotoxicity 
due to MSG. 
Glutathione-S-transferase (GST) catalyzes the 
transfer of tripeptide glutathione to endogenous and xe-
nobiotic substrates that has electrophilic functional  
groups (45). An increase in the concentration of any of 
the enzyme’s substrate increases its activities (46). Thus, 
the increase in GST activity in the group administered 
MSG alone and that administered ivermectin after 14 
days administration of MSG may be attributed to the 
substrate effect of MSG or ivermectin on the high affi-
nity transport system (43). Peroxidation of lipid yields 
malondialdehyde (MDA) as a major aldehyde product. 
It is an autocatalytic mechanism that leads to the oxi-
dative damage of cellular membranes (47). The brain is 
exceptionally predisposed to oxidative damage because 
polyunsaturated fatty acids are one of its essential 
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membrane components (48), which culminate in escalat-
ed peroxidation. An increase in MDA in groups 2 and 4 
is an indication of increased peroxidation of lipids in the 
brain, consequent of the increased level of reactive oxy-
gen species. This change was not observed in group 3 
rats possibly due to the prevention of MSG influx as a 
result of the ivermectin-p-glycoprotein interaction. 
The effects of oral administration of MSG and 
ivermectin on calcium transport was evaluated by as-
saying for intracellular Ca2+ level, and Na+ - K+ and Ca2+ - 
Mg2+ ATPase activities. The significant increase in Ca2+ 
level observed in both MSG-treated and ivermectin after 
MSG-treated groups can be attributed to two reasons; 
glutamate induction of calcium release from the endo-
plasmic reticulum inside the cell and oxidative stress-
induced impairment of Ca2+ transport and subsequent 
perturbation of intracellular Ca2+ homeostasis, resulting 
in a sustained increase in cytosolic Ca2+ concentration. 
The latter is supported by the significant decrease in Na+ 
- K+ and Ca2+ - Mg2+ ATPase, reducing the active efflux of 
Ca2+ from the cell. This corroborates the report that MSG 
caused damage to mitochondria from excessively high 
intracellular Ca2+ (30). Nitric oxide synthase (NiOS) cata-
lyses the formation of nitric oxide (NO) from arginine. 
NO is believed to be an important cellular signaling 
molecule that acts as a retrograde neurotransmitter. It is 
produced by NiOS as a defence mechanism.  
The induction of high-output of NiOS usually 
occurs in an oxidative environment, and thus high levels 
of NO have the opportunity to react with superoxide 
radical to form peroxynitrite and subsequently cause cell 
toxicity (49). The non-significant change observed in the 
NiOS activity of rats in group 3 indicated the non-oxi-
dative state of the brain tissue. This is further justified by 
a non-significant change in SOD and catalase activity of 
the rats. The prevention of influx of MSG possibly by 
ivermectin-p-glycoprotein interaction may also be attri-
buted to this observation. The increased activities of 
SOD and CAT enzymes in rats administered MSG and 
those that received ivermectin for 7 days after MSG in 
the present study is in accord with the reports of Farom-
bi and Onyema (50).  
The significant reduction in the brain ACP and 
ALP of the MSG and ivermectin after MSG-treated  
groups is suggestive of the possible lysosomal mem-
brane and plasma membrane damage, respectively. This 
may be a consequence of leakage in the membranes 
resulting in loss of theses enzymes into the surrounding 
fluids. The significant escalation in MDA concentration 
observed in this present study is an indication of an al-
teration of membrane integrity. Administration of MSG 
to neonatal rats during the first week of life has been 
documented to induce a neurodegenerative process, 
which is presented by several neurochemical alterations 
of surviving neurons in the brain (51). In addition, 
Bojanić et al. (8) hypothesized that the alteration in the 
permeability of the neural membrane and subsequent 
degradation may be caused by a high concentration of 
MSG. The effect of co-administration of MSG and iver-
mectin on ACP and ALP activities is in line with the 
earlier observation that ivermectin in the presence of 
MSG may have caused a reduced influx of MSG into the 
brain cells possibly through the p-glycoprotein of BBB. 
 
CONCLUSION 
 
The present study suggests that ivermectin may 
exert an important role in protecting against neuro- and 
excitotoxin when co-administered. This may occur pos-
sibly through the interaction of ivermectin with the p-
glycoprotein of the blood-brain barrier, thus causing a 
reduced influx of MSG into the brain. However, this 
study gives ways for further investigation on the effect 
of ivermectin on brain cell glutamate channels and Ca2+ 
pump under conditions of excitotoxicity induced by 
MSG. 
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Ivermektin deluje zaštitno kod ekscitotoksičnosti izazvane natrijum 
glutamatom kod miševa 
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SAŽETAK 
 
 
Utvrđeno je da natrijum glutamat (MSG), kao ekscitotoksični aditiv u ishrani, izaziva oksidativni stres u 
svim tkivima. Da bi se ispitali zaštitni efekti ivermektina na ekscitotoksičnost izazvanu MSG-om, dvadeset osam 
albino miševa muškog pola je podeljeno u četiri grupe. Prva, kontrolna grupa, je oralno primila 1ml destilovane 
vode; druga grupa je primila vodeni rastvor MSG-a (4 mg/kg telesne mase/ dnevno). Treća grupa je istovremeno 
primila istu dozu MSG-a i 0.4 mg/ kg telesne mase/ dnevno ivermektina, dok je četvrta grupa miševa oralno 
primala istu dozu MSG-a u toku dve nedelje, nakon čega je iveremektin oralno administriran nedelju dana. 
Davanje MSG-a oralnim putem u trajanju od 21 i 14 dana, nakon čega je usledilo oralno davanje ivermektina u 
trajanju od sedam dana, značajno je povećalo (p < 0,05) aktivnost glutation-S-transferaze, azot-oksid sintaze, 
superoksid dismutase, kao i koncentracije malondialdehida i intracelularnog Ca2+, dok je aktivnost Na+ - K+ - 
ATPase, Ca2+ - Mg2+ - ATPase, kisele fosfataze i bazne fosfataze značajno opala (p < 0,05) u poređenju sa 
kontrolnom grupom. Međutim, istovremeno davanje MSG-a i ivermektina u trajanju od 21 dana nije pokazalo 
značajnu razliku (p > 0,05) kod svih parametara u poređenju sa kontrolnom grupom. Rezultat ukazuje da 
ivermektin može da deluje zaštitno kod ekscitotoksičnosti izazvane MSG-om kod miševa. 
 
Ključne reči: natrijum glutamat, ivermektin, ekscitotoksičnost, oksidativni stres, glutamatski kanali 
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